Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Nicola Jane Latino"'
Autor:
Barbara Kiesewetter, Urania Dafni, Elisabeth G E de Vries, Jorge Barriuso, Giuseppe Curigliano, Veronica González-Calle, Martina Galotti, Bishal Gyawali, Brian Huntly, Ulrich Jaeger, Nicola Jane Latino, Luca Malcovati, Sjoukje Oosting, Gert Ossenkoppele, Martine Piccart, Markus Raderer, Lydia Scarfò, Dario Trapani, Christoph C Zielinski, Ruth Wester, Panagiota Zygoura, Elizabeth Macintyre, Nathan I Cherny
Publikováno v:
HemaSphere, Vol 7, p e02308e3 (2023)
Externí odkaz:
https://doaj.org/article/fbaa6acb8eac44379781acba442210b6
Autor:
Fatima Cardoso, Elisabeth G E de Vries, Nathan I Cherny, Urania Dafni, Nicola Jane Latino, Shani Paluch-Shimon, Martine J Piccart
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background The European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) is a validated value scale for solid tumour anticancer treatments. Form 1 of the ESMO-MCBS, used to grade therapies with curative intent including ad
Externí odkaz:
https://doaj.org/article/5ff52306a949433686bc9080ccb33158
Autor:
Elisabeth G E de Vries, Jean-Yves Douillard, Nathan I Cherny, Urania Dafni, Nicola Jane Latino, Panagiota Zygoura, Daan Geert Knapen, Derk Jan de Groot
Publikováno v:
ESMO Open, Vol 5, Iss 5 (2020)
Background Form 1 of the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) serves to grade therapies with curative intent. Hitherto only few trials with curative intent have been field tested using form 1. We aimed
Externí odkaz:
https://doaj.org/article/d2bd01f432c54e0499549d5fcf759c8c
Autor:
Karsten Nysom, Pamela Kearns, S. Griskjane, Gilles Vassal, G. Bricalli, L. Kameric, F. Arnold, Anita Kienesberger, S. Kamal, Olga Kozhaeva, Nicola Jane Latino, N. Cherny, L. Basset
Publikováno v:
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
instname
[EN] Background: Essential anticancer medicines are an indispensable component of multidisciplinary treatment of paediatric malignancies. A European Society for Medical Oncology (ESMO) study reported inequalities in the availability of anticancer med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f71b35b522b5be1e834fe003dd4d82e
https://doi.org/10.1016/j.annonc.2020.12.015
https://doi.org/10.1016/j.annonc.2020.12.015
Autor:
Elisabeth G.E. de Vries, Dimitris Karlis, Mark R. Somerfield, Richard L. Schilsky, Jean-Yves Douillard, George Pentheroudakis, Martine Piccart, Jan Bogaerts, Panagiota Zygoura, Nicola Jane Latino, Urania Dafni, Dana S. Wollins, Elizabeth Garrett-Mayer, Nathan I. Cherny, Katerina Vervita, Christoph C. Zielinski, Josep Tabernero, Shannon E. McKernin, Lowell E. Schnipper
Publikováno v:
Journal of Clinical Oncology, 37(4), 336-349. AMER SOC CLINICAL ONCOLOGY
PURPOSE To better understand the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) and the ASCO Value Framework Net Health Benefit score version 2 (ASCO-NHB v2), ESMO and ASCO collaborated to evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb211577bcbef3eee85e11519e11844
https://doi.org/10.1200/jco.18.00729
https://doi.org/10.1200/jco.18.00729
Autor:
Urania Dafni, Nathan I. Cherny, Nicola Jane Latino, Jean-Yves Douillard, Daan G Knapen, Panagiota Zygoura, Derk Jan A. de Groot, Elisabeth G.E. de Vries
Publikováno v:
ESMO Open, 5(5):e000681. BMJ PUBLISHING GROUP
ESMO Open
ESMO Open, Vol 5, Iss 5 (2020)
ESMO Open
ESMO Open, Vol 5, Iss 5 (2020)
Click here to listen to the Podcast BACKGROUND: Form 1 of the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) serves to grade therapies with curative intent. Hitherto only few trials with curative intent have bee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de6f6194e19c0509ba4207adf58f364c
https://research.rug.nl/en/publications/590c3cf2-ea12-4d66-97aa-86eb8642fce9
https://research.rug.nl/en/publications/590c3cf2-ea12-4d66-97aa-86eb8642fce9
Autor:
Nicola Jane Latino, Shani Paluch-Shimon, Elisabeth G.E. de Vries, Urania Dafni, Martine Piccart, Nathan I. Cherny, Fatima Cardoso
Publikováno v:
ESMO Open, 5 (5
ESMO Open, Vol 5, Iss 5 (2020)
ESMO Open
ESMO Open, 5(5):e000743. BMJ PUBLISHING GROUP
ESMO Open, Vol 5, Iss 5 (2020)
ESMO Open
ESMO Open, 5(5):e000743. BMJ PUBLISHING GROUP
Click here to listen to the Podcast BACKGROUND: The European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) is a validated value scale for solid tumour anticancer treatments. Form 1 of the ESMO-MCBS, used to grade therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f3cfbae3a44773bdfebef672d103e3
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/313012
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/313012
Autor:
J. Tabernero, Christoph C. Zielinski, Georgios Pentheroudakis, Urania Dafni, Nathan I. Cherny, E.G.E. de Vries, J.-Y. Douillard, Dimitris Karlis, Nicola Jane Latino, Panagiota Zygoura, Martine Piccart, Jan Bogaerts
Publikováno v:
Annals of Oncology, 29(5), 1335-1338. Oxford University Press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fb5fd51b83c84f6ba9493b23846f81a
https://doi.org/10.1093/annonc/mdy108
https://doi.org/10.1093/annonc/mdy108
Autor:
George Pentheroudakis, Nathan I. Cherny, Nicola Jane Latino, Jean-Yves Douillard, E.G.E. de Vries, Urania Dafni, Josep Tabernero, Martine Piccart, Christoph C. Zielinski, Jan Bogaerts
Publikováno v:
Annals of Oncology, 28(10), 2340-2366. Oxford University Press
Background: The ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.0 (v1.0) was published in May 2015 and was the first version of a validated and reproducible tool to assess the magnitude of clinical benefit from new cancer therapies. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40bcf80ad60a054af0c09c36d0f08c47
https://doi.org/10.1093/annonc/mdx310
https://doi.org/10.1093/annonc/mdx310
Publikováno v:
Annals of Oncology. 28:2057-2066
Background The ESMO Designated Centres (ESMO-DCs) of Integrated Oncology and Palliative Care (PC) Incentive Programme has grown steadily. We aimed to characterise the level of PC clinical services, education and research at ESMO-DCs. Methods We sent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6d25870a2c737b7e3aaf2fb830ac1b2
https://doi.org/10.1093/annonc/mdx280
https://doi.org/10.1093/annonc/mdx280